What is different about Texas, and what is not
The checks for buying personalized compounded tirzepatide safely do not change at the state line; they come from the FDA and from LegitScript. What changes is the agency that licenses and disciplines the pharmacy, and in Texas that is the Texas State Board of Pharmacy. This guide gives the checks with their sources, describes the board’s role in the board’s own words, adds the questions that belong to tirzepatide in particular, lists the red flags the FDA names, and points to the Texas pages on this site. It names no providers, and Bodi Envi’s published facts appear as one labelled example.
This is general information, not medical or legal advice. Personalized Compounded tirzepatide is not FDA-approved and is not equivalent to Zepbound® or Mounjaro®. The Texas State Board of Pharmacy’s own website is the authority on Texas pharmacy law, and this guide does not reproduce that law. A licensed provider decides whether treatment is appropriate for you.
The Texas State Board of Pharmacy
The FDA’s compounding questions and answers page explains that state boards of pharmacy generally have primary responsibility for the day to day oversight of state-licensed pharmacies that are not registered with the FDA as outsourcing facilities, the 503A pharmacies that prepare most compounded GLP-1 prescriptions, while the FDA conducts surveillance and for-cause inspections of them and primarily oversees the 503B outsourcing facilities.
The Texas State Board of Pharmacy describes itself on its website, checked in September 2026, as the state agency responsible for the licensing and registration of Texas pharmacists, pharmacy technicians and pharmacies, for establishing regulations for pharmacy practice, and for disciplining licensees and registrants. The site carries a verifications section and publishes a telephone line for complaints. For someone buying personalized compounded tirzepatide, those are the relevant functions: the board is where the standing of a pharmacy licensed in Texas can be verified and where a concern about one can be raised. This guide does not summarize Texas pharmacy regulations; the board’s pages are the source.
Bodi Envi publishes that applicable state boards of pharmacy regulate and inspect its 503A pharmacy partners and that their sterile compounding practices are subject to applicable U.S. Pharmacopeia standards. VialsRx is its current pharmacy partner for applicable GLP-1 prescriptions, availability may vary by program and patient location, and the prescription label and care team confirm the pharmacy that applies.
What to verify first
A licensed provider who evaluates you and writes a patient-specific prescription. The FDA’s statement on unapproved GLP-1 drugs advises obtaining a prescription from your doctor, and its BeSafeRx page says a safe online pharmacy always requires one; under the federal law the FDA describes, a 503A pharmacy compounds only on a patient-specific prescription.
A pharmacy you can identify and check. BeSafeRx says a safe pharmacy is licensed with a state board, has a licensed pharmacist to answer questions, and provides a United States address and telephone number. Expect the pharmacy’s name and contact details on your prescription label, and use the Texas board’s verifications section for a pharmacy licensed in the state.
A LegitScript listing. LegitScript’s healthcare certification standards require adequate licensure for the services offered and the jurisdictions served, including where medication is prescribed or dispensed and where the patient is located, dispensing only on a valid prescription, privacy compliance, no recent or repeated disciplinary action, and accurate, transparent practices and advertising. The checker at legitscript.com/websites is the verification, and certification is not FDA approval of any medication.
Published pricing with what it includes, and published cancellation and refund terms, both readable before you pay.
Questions specific to tirzepatide
The Zepbound® label describes a starting dose of 2.5 mg once weekly for four weeks, then 5 mg, then increases of 2.5 mg after at least four weeks on a dose, with 5 mg, 10 mg and 15 mg as maintenance doses; it says 2.5 mg is for initiation only and that the schedule exists to reduce gastrointestinal side effects. Ask how a provider plans the escalation and why it differs from the label if it does; the FDA’s statement reports adverse events in patients given compounded doses beyond what the label describes. Ask the concentration of the vial and how the dose is measured, since the FDA links reported hospitalizations to dosing errors with compounded GLP-1 products. If you use oral hormonal contraceptives, ask whether the provider has raised the label’s advice to switch to a non-oral method or add a barrier method for four weeks after starting and after each dose increase. And ask which kind of pharmacy prepares the medication: the FDA’s April 1, 2026 update states that tirzepatide does not currently appear on the 503B bulks list or the drug shortage list, which are the conditions under which an outsourcing facility may compound it from bulk substance, so a 503A pharmacy is the expected answer.
Personalized compounded medications differ from commercially available brand-name products in formulation, concentration, excipients, preparation methods, and other characteristics. Accordingly, clinical data from studies involving brand-name products should not be assumed to apply to personalized compounded formulations.
At this time, the studies referenced above have not evaluated the specific personalized compounded formulations being provided. Therefore, no claims of equivalence in safety, efficacy, quality, or clinical outcomes should be inferred from these studies.
Red flags the FDA names
From BeSafeRx: no prescription required, no license in the United States and with a state board of pharmacy, no licensed pharmacist to answer questions, medicine that looks different or arrives damaged, expired or without an expiration date, prices too good to be true, charges for products never ordered, and no clear written protection of personal and financial information. From the FDA’s GLP-1 statement: a claim that the compounded drug is the same as an FDA-approved drug, no screening and prescription by a licensed doctor, no doctor available afterwards, spelling errors or a wrong pharmacy address on the label, a pharmacy name that may be fraudulent, products sold as for research purposes, and medicine that arrives warm, which the FDA says not to use. The statement reports one adverse event involving a product labelled as personalized compounded tirzepatide from a pharmacy that did not compound it.
How to compare prices
Compare on what the price includes, whether it changes with dose, what happens if the provider does not prescribe, and the cancellation terms. The manufacturer’s own self pay price for Zepbound® rises with dose, so a compounded program’s price being flat or stepped is a real difference over a course of treatment; the tirzepatide cost guide on this site sets the figures side by side.
Bodi Envi’s Texas pages, as one labeled example
Bodi Envi publishes a page for personalized compounded tirzepatide in Texas and pages for the Houston and Dallas Fort Worth metros. Each carries the same published facts: the program price from $229 per month billed monthly to $175 per month on a twelve month plan, the same at every dose; the statement that a licensed healthcare provider, through Wasef Health, PC for applicable programs, determines whether treatment is appropriate; the statement that prescriptions are dispensed by third party U.S. 503A licensed compounding pharmacies; and the statement that personalized compounded tirzepatide is not FDA-approved and is not equivalent to FDA-approved products. Bodi Envi is a LegitScript-certified U.S. telehealth platform and publishes a verification link to LegitScript’s checker on every page; it is not a medical practice, pharmacy or medication manufacturer, and treatment eligibility and availability vary by individual clinical evaluation, patient location and applicable program.
Those are Bodi Envi’s own statements, offered as an example of the checks answered in writing. Apply the same checks to any provider, this one included, and use the Texas State Board of Pharmacy’s website for anything about a pharmacy’s standing in the state. This guide is general information and not medical or legal advice, and a licensed provider decides whether treatment is appropriate for you.